The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Therapeutic Plasma Exchange Global Market Report 2023, the therapeutic plasma exchange market is expected to show promising growth in the forecast period.

Recent Market Growth

• Current Growth: The therapeutic plasma exchange (TPE) market grew from $1.35 billion in 2023 to $1.47 billion in 2024, with a CAGR of 9.4%.
• Historical Drivers: Growth has been driven by the rise of immunological diseases, technological advancements, increased awareness, expanded indications for TPE, and improved understanding of disease mechanisms.

Future Market Projections

• Projected Growth: The market is expected to reach $2.12 billion by 2028, reflecting a CAGR of 9.6%.
• Future Drivers: Key factors include the aging population, clinical evidence and guidelines, supportive regulatory environments, hospital infrastructure improvements, and evolving healthcare expenditure and reimbursement policies.

Impact of Hematological Disorders on Market Growth

• Prevalence of Hematological Disorders: The high prevalence of blood disorders, including genetic, environmental, and lifestyle factors, drives market growth. TPE is used to treat these disorders by removing harmful substances from the plasma.
• Example: According to the Leukemia and Lymphoma Society, myeloma diagnoses are projected to increase from 34,920 in 2021 to 35,730 in 2023, highlighting the growing need for effective treatment options like TPE.

View More On The Therapeutic Plasma Exchange Market Report 2024 –
https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Technological Innovations

• Automated Systems: Companies are developing advanced automated plasma exchange systems to improve accuracy, efficiency, and ease of use.
• Product Launch: In May 2021, Baxter International launched the PrisMax 2 system, designed to enhance critical care delivery by simplifying TPE procedures and offering operational efficiencies.

Strategic Collaborations

• Terumo and CSL Plasma Collaboration: In April 2021, Terumo Blood and Cell Technologies partnered with CSL Plasma to improve plasma collection efficiency and safety, crucial for producing therapies for various diseases.

Market Segmentation

• By Type: Therapeutic Plasma Exchange (TPE) and Double Filtered Plasmapheresis (DFPP).
• By Indication: Neurological disorders, hematological disorders, renal disorders, metabolic disorders, and other indications.
• By Technology: Centrifugation and membrane separation.
• By End-User: Blood collection centers, hospitals and clinics, transfusion centers, and other end-users.

Regional Insights

• North America: The largest region in the therapeutic plasma exchange market in 2023, supported by advanced healthcare infrastructure and high disease prevalence.
• Asia-Pacific: Expected to be the fastest-growing region during the forecast period, driven by increasing healthcare investments and growing awareness of plasma exchange therapies.

Conclusion
The therapeutic plasma exchange market is poised for strong growth, fueled by technological advancements, rising hematological disorder prevalence, and strategic collaborations. The market’s expansion reflects ongoing innovations and increasing demand for effective plasma-based therapies.

Request A Sample Of The Global Therapeutic Plasma Exchange Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15683&type=smp